Despite these limitations, this study builds on an evolving body of literature that there may be significant benefits to using terlipressin in the ICU setting in patients with HRS-AKI.
← all excerpts
Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial.
1
—
—